Triple play: Promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus
- 1 April 2008
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 62 (4) , 218-232
- https://doi.org/10.1016/j.biopha.2008.01.009
Abstract
No abstract availableKeywords
This publication has 294 references indexed in Scilit:
- Non-canonical Wnt signaling enhances differentiation of Sca1+/c-kit+ adipose-derived murine stromal vascular cells into spontaneously beating cardiac myocytesJournal of Molecular and Cellular Cardiology, 2007
- Trends in oxidative aging theoriesFree Radical Biology & Medicine, 2007
- Wnts: up-and-coming at the synapseTrends in Neurosciences, 2007
- Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathwayApoptosis, 2007
- Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathwaysCellular Signalling, 2007
- GSK-3 is a viable potential target for therapeutic intervention in bipolar disorderNeuroscience & Biobehavioral Reviews, 2007
- A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life SpanCell, 2006
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Activation of the transcription factor NF-κB by the erythropoietin receptor: Structural requirements and biological significanceCellular Signalling, 2001
- Changes in left ventricular size, wall thickness, and function in anemic patients treated with recombinant human erythropoietinAmerican Heart Journal, 1992